Global 3D Cell Culture Market to Expand at 29% CAGR owing to Greater Research and Development Activities

  • Published On : Aug 11, 2015
The global 3D cell culture market is driven by factors such as increasing demand for organ transplantation, surging investments, and greater research and development activities. Also, the ability to replace animals in research and pharmaceutical testing is another prominent factor that drives the global 3D cell culture market. 3D cell culture refers to an artificially created environment that enables cells to grow, thrive, and interact with its surroundings within the three different dimensions. 

This advanced technique overcomes the limitations posed by 2D cell culture and helps in detailed and better understanding of cellular behavior and cellular characteristics. The widespread adoption of 3D cell culture can mainly be seen in biotechnology companies, biopharmaceutical firms, research centers, and most importantly, hospitals. The global 3D cell culture market is projected to expand at a promising CAGR of 29.1% from 2014 to 2020, thereby reaching a market value of US$2717.6 million by 2020 from US$586.1 million in 2014. 

Which Technology Segment Holds the Highest Share?

The global 3D cell culture market is segmented on the basis of technology, application, end users, and geography. On the basis of technology, this market is categorized into microchips, scaffold-free platforms, bioreactors, gels, and extracellular matrices or scaffolds. The segment for extracellular matrices or scaffolds holds the largest share in the global 3D cell culture market. 

Application-wise, the global 3D cell culture market is segmented into stem cell biology, tissue engineering, clinical application, research, and drug development and testing.

The various end users in the 3D cell culture market are hospital and diagnostic centers, research laboratories and institutes, pharmaceutical and biotechnology companies, and others. Biopharmaceutical industries and biotechnology companies are by far the largest users of the 3D cell culture technique. 

3D cell culture is a widely accepted and preferred method for examining disease models since this technique drives normal cell proliferation, morphology, migration, and also differentiation. Lack of consistency in products hampers the growth of the global 3D cell culture market, and budgetary constraints also affect the market demand negatively. 

Automation: A Key Trend in the Global 3D Cell Culture Markets

A key trend in the global 3D cell culture market is the increasing use of automation, which apart from being time-saving, increases the convenience factor associated with research and evaluation. 

Geographically, the global 3D cell culture market is segmented into Asia, North America, Europe, and Rest of the World. The global 3D cell culture market is dominated by Europe, which in 2014 stood at US$234.4 million and will expand at a healthy CAGR of 28.7% during the forecast period. 

By 2020, the Europe 3D cell culture market is anticipated to reach a market value of US$1067.8 million owing to greater research and development and widespread adoption of the 3D cell culture technology. Rapidly increasing use of microfluidic technology, coupled with shift of focus of the global 3D cell culture market towards regenerative medicine, is expected to create gainful growth opportunities in the years to come. 

The prominent companies operating in the global 3D cell culture market are Sigma-Aldrich Corporation, InSphero AG, Global Cell Solutions Inc., 3D Biomatrix Inc., 3D Biotech LLC, Lonza Group, Becton, Dickinson and Company, and Corning Incorporated.

Browse Full Global 3D Cell Culture Market Research Report With Complete TOC @
Back To Top